To evaluate the incidence and risks of adverse events associated with therapy (both corticosteroids [CS] and nonsteroidal antiinflammatory drugs [NSAIDs]) among a previously identified, population-based cohort of patients first diagnosed with polymyalgia rheumatica (PMR) between 1970 and 1991 who were followed up over the long term
Polymyalgia rheumatica (PMR) is the commonest inflammatory rheumatic disease affecting older people....
Objectives A series of patients with polymyalgia rheumatica (PMR) who received the steroid-sparing ...
Polymyalgia rheumatica (PMR) is an inflammatory condition of unknown etiology characterized by achin...
To evaluate the incidence and risks of adverse events associated with therapy (both corticosteroids ...
To assess the occurrence of adverse events in a cohort of patients with polymyalgia rheumatica (PMR)...
Arthur E Brawer Division of Rheumatology, Department of Medicine, Monmouth Medical Center, Long Bran...
Objectives: To determine the burden of comorbidities, including glucocorticoid (GC) related adverse ...
Glucocorticoids (GC) are the mainstay of treatment of polymyalgia rheumatica (PMR). However GC-relat...
International audienceGlucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) ...
To investigate whether infliximab has a steroid-sparing effect in the treatment of patients with pol...
Objective. To assess the clinical outcome of patients with polymyalgia rheumatica (PMR) and giant ce...
*<p>cases of PMR were defined as all ADR-reports of PMR.</p>†<p>only ADR-reports reported by physici...
Polymyalgia rheumatica (PMR) is commonly found in Northern Europe and in persons of Scandinavian ext...
Objective. To determine laboratory parameters that may be useful in identifying polymyalgia rheumati...
Background: Immune checkpoint inhibitors (ICPIs) induce immune-related adverse events (irAEs) such a...
Polymyalgia rheumatica (PMR) is the commonest inflammatory rheumatic disease affecting older people....
Objectives A series of patients with polymyalgia rheumatica (PMR) who received the steroid-sparing ...
Polymyalgia rheumatica (PMR) is an inflammatory condition of unknown etiology characterized by achin...
To evaluate the incidence and risks of adverse events associated with therapy (both corticosteroids ...
To assess the occurrence of adverse events in a cohort of patients with polymyalgia rheumatica (PMR)...
Arthur E Brawer Division of Rheumatology, Department of Medicine, Monmouth Medical Center, Long Bran...
Objectives: To determine the burden of comorbidities, including glucocorticoid (GC) related adverse ...
Glucocorticoids (GC) are the mainstay of treatment of polymyalgia rheumatica (PMR). However GC-relat...
International audienceGlucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) ...
To investigate whether infliximab has a steroid-sparing effect in the treatment of patients with pol...
Objective. To assess the clinical outcome of patients with polymyalgia rheumatica (PMR) and giant ce...
*<p>cases of PMR were defined as all ADR-reports of PMR.</p>†<p>only ADR-reports reported by physici...
Polymyalgia rheumatica (PMR) is commonly found in Northern Europe and in persons of Scandinavian ext...
Objective. To determine laboratory parameters that may be useful in identifying polymyalgia rheumati...
Background: Immune checkpoint inhibitors (ICPIs) induce immune-related adverse events (irAEs) such a...
Polymyalgia rheumatica (PMR) is the commonest inflammatory rheumatic disease affecting older people....
Objectives A series of patients with polymyalgia rheumatica (PMR) who received the steroid-sparing ...
Polymyalgia rheumatica (PMR) is an inflammatory condition of unknown etiology characterized by achin...
DOI
Add to ORKG